302
Participants
Start Date
February 28, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
May 31, 2012
UFOX + Cetuximab
"* Cetuximab infusion (400 mg/m\^2 on day 1 of cycle 1 and 250 mg/m\^2 at each subsequent day 1, as well as on days 8, 15 and 22)~* Oxaliplatin infusion (85mg/m\^2) on days 1 and 15 (every 2 weeks)~* Oral UFT® (250mg/m\^2 tegafur + 560 mg/m\^2 uracil in 3 daily doses rounded to the nearest number of whole capsules) on days 1-21~* Oral Folinic Acid (90 mg in 3 daily divided doses) on days 1-21"
FOLFOX4 + Cetuximab
"* Cetuximab infusion (400 mg/m\^2 on day 1 of cycle 1 and 250 mg/m\^2 at each subsequent day 1, as well as on days 8, 15 and 22)~* Oxaliplatin infusion (85 mg/m\^2) on days 1 and 15 (every 2 weeks)~* 5-FU bolus + infusions (400 mg/m\^2) on days 1, 2, 15 and 16~* Folinic Acid infusions (200 mg/m\^2) on days 1, 2, 15 and 16"
Research Site, Buenos Aires
Research Site, Ciudad Autónoma Buenos Aires
Research Site, Perth
Research Site, Wollongong
Research Site, Graz
Research Site, Vienna
Research Site, Leuven
Research Site, Liège
Research Site, Belo Horizonte
Research site, Cep Sao Paulo-SP
Research Site, Fortaleza
Research Site, Besançon
Research Site, Caen
Research Site, La Roche-sur-Yon
Research Site, Lille
Research Site, Marseille
Research Site, Nice
Research Site, Saint-Herblain
Research Site, Strasbourg
Research Site, Berlin
Research Site, Dortmund
Research Site, Dresden
Research Site, Frankfurt am Main
Research Site, Hamburg
Research Site, Hanover
Research Site, Heidelberg
Research Site, Kassel
Research Site, Krefeld
Research Site, Magdeburg
Research Site, München
Research Site, Oldenburg
Research Site, Wiesbaden
Research Site, Dragana
Research Site, Thessaloniki
Research Site, Voútai
Research Site, Hong Kong
Research Site, Shatin
Research Site, Haifa
Research Site, Jerusalem
Research Site, Benevento
Research Site, Brescia
Research Site, Cremona
Research Site, Forlì
Research Site, Padua
Research Site, Pavia
Research Site, Potenza
Research Site, Reggio Emilia
Research Site, Rimini
Research Site, Roma
Research Site, Sassari
Research Site, Mexico City
Research Site, Krakow
Research Site, Lublin
Research Site, Opole
Research Site, Warsaw
Research Site, Bangkok
Research Site, Pathumwan
Merck KGaA, Darmstadt, Germany
INDUSTRY